PREVALENCE OF RUBELLA IGG ANTIBODIES AMONG PRODUCTIVE-AGE ‎WOMEN IN AL-MAHWEET GOVERNORATE, YEMEN

  • Amatalkhaliq Abdullah Gobara'a Medical Laboratory Department, Faculty of Medical Sciences, Sana’a University, Yemen.
  • Wadhah Hassan Edrees Medical Laboratory Department, Faculty of Medical Sciences, Al-Razi University, Yemen
  • Wadee Abdullah Al-Shehari Department of Microbiology, Faculty of Medical Sciences, Ibb University, Yemen.
  • Anwar Al-Madhagi Medical Laboratory Department, Faculty of Medical Sciences, Sana’a University, Yemen.
  • Khaled Al-Moyed Medical Laboratory Department, Faculty of Medical Sciences, Sana’a University, Yemen.
  • Maged Mohammed Almezgagi Medical Laboratory Department, Faculty of Medical Sciences, Sana’a University, Yemen.
  • Alariqi Reem Medical Laboratory Department, Faculty of Medical Sciences, Sana’a University, Yemen.
10.22270/ujpr.v5i4.436

Keywords:

Al-Mahweet, Antibody, IgG, Prevalence, Rubella virus, Women, Yemen

Abstract

Background: Rubella is an infectious viral disease that caused by the Rubella virus. The incidence of rubella infection in women during pregnancy leads to complications for fetus development and cause congenital rubella syndrome or fetal death. This study aimed to determine the prevalence rate of rubella among reproductive-age women in Al-Mahweet, Yemen.

Methods: A cross sectional study was conducted among females attending healthcare centers and schools from July 2007 to June 2008. Blood samples were collected individually from 270 females aged 15-35 years and the rubella virus IgG antibody was quantitated by enzyme-linked immunosorbent assay (ELISA). The needed data were collected by using a pretested questionnaire and analyzed by statistical program.

Results: Overall, 197(73%) had IgG-positive antibody to rubella and 73(27%) had IgG-negative antibody to rubella. The highest rate of anti-rubella IgG was among females aged 15-25 years and the lowest was among the females aged 31-35 years. Similarly, the higher rate was among females living in urban area compared to females from rural area. The statistically significant difference was found between most educational levels and positive results of anti-rubella IgG. With regard to marital status, the most frequent of rubella antibody was 72.3%, 73.1%, and 75.0%, respectively, recorded among single, married, and divorced females. The non-pregnant women had (73.7%) more incidence to rubella IgG antibody than pregnant (66.7%). 82.2% of IgG- positive women had no history of stillbirth and 65% had a history of stillbirth.

Conclusions: Most of the enrolled females had immunity against rubella virus, but still a significant percentage were susceptible to rubella infection. Thus, it is essential to introduce of rubella vaccine to control and prevent the rubella virus circulating among the community.

                          r61.gif

Peer Review History:

Received 1 June 2020; Revised 9 July; Accepted 20 August; Available online 15 September 2020

Academic Editor: Dr. DANIYAN Oluwatoyin Michaelorcid22.jpg, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com

 Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 6.0/10

Average Peer review marks at publication stage: 8.0/10

Reviewer(s) detail:

Dr. A.A. Mgbahurikeorcid2.jpg, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com

Dr. Tamer Elhabibiorcid2.jpg, Egyptian Russian University, Egypt, Tamer_elhabibi@yahoo.com

Rawaa S. Al-Kayaliorcid2.jpg, Aleppo university, biochemistry and microbiology department, Syria, Rawah67@hotmail.com

Rola jadallahorcid2.jpg, Arab American University, Palestine, rolla.jadallah@aaup.edu

Downloads

Download data is not yet available.
Crossmark
Statistics
552 Views | 201 Downloads
Dimension Citations

Published

2020-09-15

How to Cite

Gobara’a, A. A., W. H. Edrees, W. A. Al-Shehari, A. Al-Madhagi, K. Al-Moyed, M. M. Almezgagi, and A. Reem. “PREVALENCE OF RUBELLA IGG ANTIBODIES AMONG PRODUCTIVE-AGE ‎WOMEN IN AL-MAHWEET GOVERNORATE, YEMEN”. Universal Journal of Pharmaceutical Research, vol. 5, no. 4, Sept. 2020, doi:10.22270/ujpr.v5i4.436.

Issue

Section

Research Articles
Share |

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

You may also start an advanced similarity search for this article.